Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Mar 24, 2026
Why Is Concentrix Corporation (CNXC) Stock Down -11% Today?

Why Is Concentrix Corporation (CNXC) Stock Down -11% Today?

Key Takeaways

  • Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open.
  • Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
  • Net income plunged 69.3% year-over-year, and operating income fell 29.8%, signaling severe profitability compression despite top-line growth.
  • Revenue of $2.50 billion grew 5.4% year-over-year but fell short of certain analyst estimates near $2.54 billion.
  • Full-year fiscal 2026 guidance was maintained, not raised — viewed by markets as lacking the upside surprise needed to justify the pre-earnings run-up.
  • Investors will be watching the 8:30 a.m. ET earnings call closely for management commentary on margin recovery and debt management.

Opening Summary

Concentrix Corporation (CNXC) is a global leader in customer experience (CX) management and technology-enabled business services, serving clients across industries including technology, financial services, retail, and healthcare. Shares are trading approximately 11% lower in Tuesday premarket activity, declining to roughly $28.05 from the prior session's close of approximately $31.52, following the release of disappointing fiscal Q1 2026 results.  While headline revenue grew year-over-year, the print revealed a dramatic deterioration in profitability that rattled investors — net income fell 69.3% versus the same period last year.  The earnings-driven selloff reflects deepening concerns about CNXC's margin trajectory in a highly competitive, cost-intensive CX landscape.

Earnings Miss on Profitability

Concentrix reported fiscal Q1 2026 revenue of $2,500.4 million, up 5.4% year-over-year from $2,372.2 million, but falling short of some analyst estimates pegged near $2.54 billion.   On the bottom line, adjusted diluted EPS of $2.61 missed the consensus of approximately $2.64 — a modest figure in isolation, but one that, when paired with the broader profitability collapse, intensified investor concern.  The slight top-line beat versus the company's own guidance range of $2.475–$2.500 billion offered little consolation given the scale of margin deterioration elsewhere in the report.

Profitability Under Severe Pressure

The most alarming figures came from within the income statement. Operating income fell 29.8% year-over-year to $118.6 million, compared with $168.9 million in Q1 2025.  Net income declined an even steeper 69.3%, a figure that markets viewed as alarming rather than temporary.  Adjusted EBITDA came in at $348.2 million versus $374.2 million in the prior-year period — a roughly 7% decline even in the company's most favorable profitability metric.  These figures reflect what management has framed as transition-related headwinds, including costs tied to its acquisition-integration program and an ongoing operational transformation.

Guidance: Maintained, Not Upgraded

Concentrix reiterated its full fiscal year 2026 outlook, maintaining non-GAAP diluted EPS guidance of $11.48 to $12.07 and revenue of $10.04 billion to $10.18 billion.  While guidance maintenance signals management's confidence in hitting full-year targets, it provided no upward revision to lift sentiment. This proved to be a critical disappointment: ahead of the report, CNXC shares had surged nearly 5% to $33.04 in early premarket trading, implying elevated investor expectations.  The sharp reversal after the results points to the market penalizing the company for failing to deliver any forward-looking catalyst alongside profitability weakness.

Market Context and Trading Activity

The sell-off arrives at a particularly vulnerable moment for CNXC shares, which entered today's session already down more than 20% year-to-date and approximately 50% below their 52-week high of $65.04, reached in early 2025.  The stock has experienced several significant single-session drops in recent months, including a 6.1% decline in mid-March and a 5.1% drop in early March, establishing a pattern of weak price action.   Today's gap-down is expected to bring dramatically elevated volume when the regular session opens, as the size of the premarket move will attract both liquidation by institutional holders and tactical interest from contrarian buyers. The broader technology and business services sector has not experienced similar pressure, reinforcing that this is a company-specific earnings event rather than a macro- or sector-driven move.

Trending AI Robots

For traders navigating volatile earnings moves like today's in CNXC, Tickeron's Trending AI Robots page offers a curated look at the platform's top-performing automated trading strategies. Tickeron operates hundreds of AI-powered trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in this dedicated section. The bots vary by strategy type, risk profile, timeframe, and the specific symbols they trade — giving traders a data-driven starting point for finding approaches suited to today's environment. Whether you favor short-term momentum plays around earnings or more measured swing-trading strategies, exploring the Trending AI Robots page can help identify AI-driven strategies that align with your objectives.

What Comes Next for CNXC

The immediate focus shifts to the earnings conference call at 8:30 a.m. ET on March 24, where Concentrix management will need to address the scale of profitability deterioration and outline a credible path toward margin recovery.  Key investor questions will center on the speed of cost rationalization, the margin contribution of AI-enhanced CX services, and how the company plans to manage its leverage — with a debt-to-equity ratio near 1.67, interest expense remains a material drag.  Analysts currently maintain a consensus "Hold" rating with price targets well above current trading levels, reflecting a view that long-term value exists but near-term execution risk remains elevated.  Until CNXC demonstrates consistent improvement in operating and net margins over successive quarters, sentiment is likely to remain cautious. The next earnings report is expected in Q2 2026, and any upward guidance revision at that point would be a key potential re-rating catalyst.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: CNXC

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


Aroon Indicator for CNXC shows an upward move is likely

CNXC's Aroon Indicator triggered a bullish signal on August 28, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 191 similar instances where the Aroon Indicator showed a similar pattern. In 142 of the 191 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

CNXC moved above its 50-day moving average on August 19, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +8.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNXC advanced for three days, in 205 of 297 cases, the price rose further within the following month. The odds of a continued upward trend are 69%.

Bearish Trend Analysis

The 10-day RSI Indicator for CNXC moved out of overbought territory on September 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 23 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 82%.

The Momentum Indicator moved below the 0 level on September 14, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNXC as a result. In 64 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.

The Moving Average Convergence Divergence Histogram (MACD) for CNXC turned negative on September 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In 33 of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNXC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

CNXC broke above its upper Bollinger Band on September 01, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.630) is normal, around the industry mean (7.717). P/E Ratio (8.576) is within average values for comparable stocks, (69.115). Projected Growth (PEG Ratio) (0.354) is also within normal values, averaging (2.305). CNXC's Dividend Yield (0.052) is considerably higher than the industry average of (0.010). P/S Ratio (0.180) is also within normal values, averaging (145.217).

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating steady price growth. CNXC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 89 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNXC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 8.84B. The market cap for tickers in the group ranges from 100 to 216.27B. IBM holds the highest valuation in this group at 216.27B. The lowest valued company is ARSC at 100.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 1%. For the same Industry, the average monthly price growth was -4%, and the average quarterly price growth was 27%. DAIC experienced the highest price growth at 59%, while VEEA experienced the biggest fall at -37%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was -5%. For the same stocks of the Industry, the average monthly volume growth was -9% and the average quarterly volume growth was -29%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 48
P/E Growth Rating: 64
Price Growth Rating: 59
SMR Rating: 72
Profit Risk Rating: 92
Seasonality Score: -3 (-100 ... +100)
View a ticker or compare two or three
CNXC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of active thermal coal operations

Industry InformationTechnologyServices

Industry
Coal
Address
39899 Balentine Drive
Phone
+1 800 747-0583
Employees
455000
Web
https://www.concentrix.com
Interact to see
Advertisement
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.